Diagnosis and assessment of patients with prostate cancer is dependent on accurate
interpretation and grading of histopathology. However, morphology does not necessarily …

The presence of intraductal carcinoma of the prostate (IDCP) correlates with late-stage
disease and poor outcomes for patients with prostatic adenocarcinoma, but the accurate and …

Prostate cancer is the second most common cancer in men worldwide. Gleason grading is
an important predictor of prostate cancer outcomes and is influential in determining patient …

Simple Summary A novel biomarker panel (Appl1, Sortilin and Syndecan-1) was
demonstrated as a strong independent predictor for both clinical and biochemical …

Prostate cancer (PCa) development and progression relies on the programming of glucose
and lipid metabolism, and this involves alterations in androgen receptor expression and …

Prostate cancer (PCa) is the second most frequently diagnosed cancer in men. Despite the
significant progress in cancer diagnosis and treatment over the last few years, the approach …

Background: Compared to non-recurrent type, recurrent prostate adenocarcinoma (PCa) is
highly fatal, and significantly shortens the survival time of affected patients. Early and …

Background: The early detection of prostate cancer has resulted in an increase in the
number of patients with localized prostate cancer and has paralleled the reported reduction …

Levels of 27 transcripts were investigated as potential novel markers for prostate cancer,
including genes encoding plasma membrane proteins (ADAM2, ELOVL5, MARCKSL1 …

While localised prostate cancer can be cured by local treatment,'high-risk'prostate cancer
often progresses to castration resistant disease and remains incurable with a dismal …